{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T16:37:32Z","timestamp":1766507852565,"version":"3.48.0"},"reference-count":13,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,23]]},"DOI":"10.1182\/bloodadvances.2025016749","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T20:37:01Z","timestamp":1755203821000},"page":"6534-6537","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["A patient-derived CABIN1 mutation recapitulates features of idiopathic multicentric Castleman disease in a mouse model"],"prefix":"10.1182","volume":"9","author":[{"given":"Dorottya","family":"Laczko","sequence":"first","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Tsao","sequence":"additional","affiliation":[{"name":"2Center for Cytokine Storm Treatment & Laboratory, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9413-7611","authenticated-orcid":false,"given":"Ruth-Anne","family":"Pai","sequence":"additional","affiliation":[{"name":"2Center for Cytokine Storm Treatment & Laboratory, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5120-5386","authenticated-orcid":false,"given":"Joseph","family":"Zinski","sequence":"additional","affiliation":[{"name":"2Center for Cytokine Storm Treatment & Laboratory, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael V.","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"2Center for Cytokine Storm Treatment & Laboratory, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2145-8347","authenticated-orcid":false,"given":"Melanie D.","family":"Mumau","sequence":"additional","affiliation":[{"name":"2Center for Cytokine Storm Treatment & Laboratory, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8944-3278","authenticated-orcid":false,"given":"Tobias","family":"Raabe","sequence":"additional","affiliation":[{"name":"3Division of Translational Medicine and Human Genetics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1544-1493","authenticated-orcid":false,"given":"Hiromi","family":"Muramatsu","sequence":"additional","affiliation":[{"name":"4Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Pardi","sequence":"additional","affiliation":[{"name":"4Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taku","family":"Kambayashi","sequence":"additional","affiliation":[{"name":"1Department of Pathology and Laboratory Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7367-8184","authenticated-orcid":false,"given":"David C.","family":"Fajgenbaum","sequence":"additional","affiliation":[{"name":"2Center for Cytokine Storm Treatment & Laboratory, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"issue":"2","key":"2025122309461645900_bib1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3960\/jslrt.22010","article-title":"Candidate biomarkers for idiopathic multicentric Castleman disease","volume":"62","author":"Sumiyoshi","year":"2022","journal-title":"J Clin Exp Hematop"},{"issue":"12","key":"2025122309461645900_bib2","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1182\/blood-2016-10-746933","article-title":"International, evidence-based consensus diagnostic criteria for HHV-8-negative\/idiopathic multicentric Castleman disease","volume":"129","author":"Fajgenbaum","year":"2017","journal-title":"Blood"},{"issue":"9","key":"2025122309461645900_bib3","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1056\/NEJM199403033300904","article-title":"Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody","volume":"330","author":"Beck","year":"1994","journal-title":"N Engl J Med"},{"issue":"8","key":"2025122309461645900_bib4","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/02841860410002752","article-title":"Fifty years of multicentric Castleman's disease","volume":"43","author":"Waterston","year":"2004","journal-title":"Acta Oncol"},{"issue":"30","key":"2025122309461645900_bib5","doi-asserted-by":"crossref","first-page":"30408","DOI":"10.18632\/oncotarget.4655","article-title":"A phase 2, open-label, multicenter study of the long-term safety of siltuximab (an anti-interleukin-6 monoclonal antibody) in patients with multicentric Castleman disease","volume":"6","author":"van Rhee","year":"2015","journal-title":"Oncotarget"},{"issue":"23","key":"2025122309461645900_bib6","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1200\/JCO.2009.27.2377","article-title":"Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman's disease","volume":"28","author":"van Rhee","year":"2010","journal-title":"J Clin Oncol"},{"issue":"9","key":"2025122309461645900_bib7","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S1470-2045(14)70319-5","article-title":"Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial","volume":"15","author":"van Rhee","year":"2014","journal-title":"Lancet Oncol"},{"issue":"19","key":"2025122309461645900_bib8","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1182\/blood.2019002792","article-title":"Increased mTOR activation in idiopathic multicentric Castleman disease","volume":"135","author":"Arenas","year":"2020","journal-title":"Blood"},{"issue":"10","key":"2025122309461645900_bib9","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1172\/JCI126091","article-title":"Identifying and targeting pathogenic PI3K\/AKT\/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease","volume":"129","author":"Fajgenbaum","year":"2019","journal-title":"J Clin Invest"},{"issue":"2","key":"2025122309461645900_bib10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ajh.26783","article-title":"Refractory idiopathic multicentric Castleman disease responsive to sirolimus therapy","volume":"98","author":"Bayram","year":"2023","journal-title":"Am J Hematol"},{"issue":"10","key":"2025122309461645900_bib11","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1084\/jem.194.10.1449","article-title":"Deletion of calcineurin and myocyte enhancer factor 2 (MEF2) binding domain of Cabin1 results in enhanced cytokine gene expression in T cells","volume":"194","author":"Esau","year":"2001","journal-title":"J Exp Med"},{"issue":"16","key":"2025122309461645900_bib12","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1182\/blood.2019000931","article-title":"Overview of Castleman disease","volume":"135","author":"Dispenzieri","year":"2020","journal-title":"Blood"},{"issue":"81","key":"2025122309461645900_bib13","doi-asserted-by":"crossref","first-page":"eadf2248","DOI":"10.1126\/sciimmunol.adf2248","article-title":"The transcription factor Mef2d regulates B:T synapse-dependent GC-T(FH) differentiation and IL-21-mediated humoral immunity","volume":"8","author":"Kim","year":"2023","journal-title":"Sci Immunol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/24\/6534\/2475767\/blooda_adv-2025-016749-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/24\/6534\/2475767\/blooda_adv-2025-016749-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T14:46:26Z","timestamp":1766501186000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/24\/6534\/546724\/A-patient-derived-CABIN1-mutation-recapitulates"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":13,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2025,12,23]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025016749","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"type":"print","value":"2473-9529"},{"type":"electronic","value":"2473-9537"}],"subject":[],"published-other":{"date-parts":[[2025,12,23]]},"published":{"date-parts":[[2025,12,15]]}}}